Swiss Fintech Relio secures CHF 3 million in financing for the launch of a digital payment account for business customers. With its newly developed compliance technology, the startup specializes primarily in complex corporate clients. The Fintech
As we have informed here, Lab14, a portfolio company of RSBG SE, the investment company of the RAG-Foundation, has acquired a majority stake in Liestal-based Nanosurf. Nanosurf is one of the leading innovators in the
Vertical farming startup YASAI received an undisclosed amount from the Bell Food Group in a convertible loan round. The Zurich based startup is also welcoming the Group’s CEO, Lorenz Wyss, to its board of
Niederer Kraft Frey has advised SWISSto12 on its negotiations with the European Space Agency (ESA). Its new product line HummingSat, developed in partnership with ESA, is the first product in the telecommunications satellite product line
Homburger has advised Raiffeisen Schweiz Genossenschaft on all legal, regulatory and tax aspects of the spin-off of its 6 branches into independent Raiffeisen banks. The team was led by René Bösch (financial market regulation) and
Dufour Aerospace has announced that it successfully completed a Series B investment from Vista Global Holding, the world’s leading global private aviation group, further supporting the continued development of sustainable aviation technologies. In addition
Swiss proptech Properti has successfully completed its Pre-Series A financing round. The startup received a total of CHF three million. This brings the company’s total capital raised in the past 12 months to over CHF 10
The US-based payments specialist Shift4, a publicly-traded global leader in commerce technology solutions, has acquired Online Payments Group, which operates the online payments platform
Cité Gestion, a Swiss bank and wealth manager, has issued its shares in the form of ledger-based securities -a process often referred to as “tokenization”- and obtained the CMTA. Tokenized Shares certification. The Swiss
As we have informed here, the AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys, a clinical-stage company based in Basel, Switzerland. The
